by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by Stem Cell Network | May 11, 2012
By all accounts, the 35 entries in this year’s Cells I See Art Contest & Gallery Showing were among the best we’ve ever had. Certainly, there were more than we’d ever seen before (view them all here) — so many, in fact, that we had...
by David Kent | May 8, 2012
The final day of the 2012 Till and McCulloch Meetings was packed with great science, but a common theme definitely emerged – technological advances are changing the way we think about and perform scientific research. Keynote speaker Helen Blau issued a warning...
by Paul Krzyzanowski | May 4, 2012
Commercialization plenary summary: part 3 of 4 On day two (May 1) of the Till and McCulloch Meetings, Dr. Emily Culme-Seymour from the London Regenerative Medicine Network introduced work that leverages previous clinical trial information to support future cell...
by David Kent | May 2, 2012
Anticipatory ethics and the problem of expectations One of my favorite things about Canadian Stem Cell Network meetings (now renamed the Till and McCulloch Meetings) is the integration into the main programming of Ethical, Legal, and Social Issues (ELSI). It...
by Paul Krzyzanowski | May 1, 2012
Commercialization plenary summary, part 2 of 4 One of the most dynamic speakers of the conference thus far was Greg Bonfiglio of Proteus Venture Partners. A well-known VC speaker in this area, Bonfiglio shared his perspectives of how the commercialization of...
by Paul Krzyzanowski | May 1, 2012
Commercialization plenary summary, part 1 of 4 Till and McCulloch Meeting (#TMM2012) attendees in Montreal had the opportunity to hear from four speakers involved in commercializing discoveries in regenerative medicine, from the perspectives of not-for-profit,...
by Lisa Willemse | Apr 24, 2012
An interview with Till & McCulloch Award winner, Dr. Aaron Schimmer, whose paper, entitled “Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia,” published in Cancer Cell, November 2011, was selected by committee as...
by Angela C. H. McDonald | Apr 17, 2012
Most research on stem cells involves the manipulation of gene expression, to some degree or another. During stem cell differentiation, the expression of specific genes orchestrates the choices cells make along the path from stem cell to adult cell — a process...
Comments